|
Q3 FY2026
As of Sep 30, 2026
|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||||||||
| Current assets: | |||||||||||||||||||
| Cash and cash equivalents | |||||||||||||||||||
| Short-term investments | |||||||||||||||||||
| Prepaid expenses and other current assets | |||||||||||||||||||
| Total current assets | |||||||||||||||||||
| Long-term investments | |||||||||||||||||||
| Other assets, long-term | |||||||||||||||||||
| Total assets | |||||||||||||||||||
| Liabilities and stockholders' equity | |||||||||||||||||||
| Current liabilities: | |||||||||||||||||||
| Accounts payable | |||||||||||||||||||
| Accrued compensation | |||||||||||||||||||
| Accrued liabilities | |||||||||||||||||||
| Other current liabilities | |||||||||||||||||||
| Options subject to repurchase, short-term | |||||||||||||||||||
| Total current liabilities | |||||||||||||||||||
| Other non-current liabilities | |||||||||||||||||||
| Total liabilities | |||||||||||||||||||
| Stockholders' equity: | |||||||||||||||||||
| Additional paid-in capital | |||||||||||||||||||
| Accumulated other comprehensive (loss) gain | |||||||||||||||||||
| Accumulated deficit | |||||||||||||||||||
| Total stockholders' equity | |||||||||||||||||||
| Total liabilities and stockholders' equity | |||||||||||||||||||
Loading...